Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease (PLoS ONE (2019) 14:7 (e0210308) DOI: 10.1371/journal.pone.0210308)

Fatma N. Hamed; Annika Åstrand; Marta Bertolini; Alfredo Rossi; Afsaneh Maleki-Dizaji; Andrew G. Messenger; Andrew J.G. McDonagh; Rachid Tazi-Ahnini

ArticleOPEN ACCESS

Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease (PLoS ONE (2019) 14:7 (e0210308) DOI: 10.1371/journal.pone.0210308)

PLoS ONE

DOI: 10.1371/journal.pone.0222473

5Citations

16Readers

Abstract

The following information is missing from the Funding section: MB received funding from the National Alopecia Areata Foundation (USA) and Associazione Mediterranea Alopecia Areata (Italy).

Cite

CITATION STYLE

APA

Hamed, F. N., Åstrand, A., Bertolini, M., Rossi, A., Maleki-Dizaji, A., Messenger, A. G., … Tazi-Ahnini, R. (2019, September 1). Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease (PLoS ONE (2019) 14:7 (e0210308) DOI: 10.1371/journal.pone.0210308). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0222473

Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease (PLoS ONE (2019) 14:7 (e0210308) DOI: 10.1371/journal.pone.0210308)

Abstract

Cite

Register to see more suggestions